TRUSOPT

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug TRUSOPT contains one active pharmaceutical ingredient (API):

1	Dorzolamide UNII QZO5366EW7 - DORZOLAMIDE HYDROCHLORIDE
	Dorzolamide is a potent inhibitor of human carbonic anhydrase II. Following topical ocular administration, dorzolamide reduces elevated intra-ocular pressure, whether or not associated with glaucoma.
	Read more about Dorzolamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TRUSOPT Eye drops, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EC03	Dorzolamide	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EC Carbonic anhydrase inhibitors
Discover more medicines within S01EC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5541P, 8488R
BR	Câmara de Regulação do Mercado de Medicamentos	525502401173413, 556717100001417
CA	Health Products and Food Branch	02216205, 02269090
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00064997, 00990617, 00990623, 01087144, 01087150, 01607951, 01607968, 01607980, 01813969, 01813975, 01813981, 02199744, 02531598, 03245297, 03245328, 03245334, 03781541, 03781558, 03781564, 06437867, 06437873, 06437904, 07186290, 07186309, 09073704, 09073710, 11103507, 11103513, 16806969, 17264364, 17264370, 17448348
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	21.469-1-07-04
EE	Ravimiamet	1014961
ES	Centro de información online de medicamentos de la AEMPS	60651
FI	Lääkealan turvallisuus- ja kehittämiskeskus	115642
FR	Base de données publique des médicaments	69918085
GB	Medicines & Healthcare Products Regulatory Agency	102713, 13847, 140145, 374160
HK	Department of Health Drug Office	40713
HR	Agencija za lijekove i medicinske proizvode	HR-H-471662399
IE	Health Products Regulatory Authority	57503, 57555, 57580
IL	מִשְׂרַד הַבְּרִיאוּת	3562
IT	Agenzia del Farmaco	031848056
JP	医薬品医療機器総合機構	1319738Q1024, 1319738Q2020
LT	Valstybinė vaistų kontrolės tarnyba	1002224, 1074624
MT	Medicines Authority	AA1068/00501, AA1068/00502, AA565/29202
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	522M95
NL	Z-Index G-Standaard	13906550
NL	Z-Index G-Standaard, PRK	41556, 81027
NZ	Medicines and Medical Devices Safety Authority	7153
PL	Rejestru Produktów Leczniczych	100068271
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62676001, W62676002
SG	Health Sciences Authority	08880P
ZA	Health Products Regulatory Authority	29/15.4/0766